VANCOUVER, BC – Izotropic Corporation (“Izotropic” or the “Company”) (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) a Company commercializing a dedicated breast CT (computed tomography) imaging platform, IzoView, for the more accurate detection… Read More
Bamlanivimab and etesevimab administered together neutralize the Delta variant, which is currently the cause of over 95 percent of new COVID-19 infections in the EU/EEA Participating EU/EEA countries can purchase… Read More
VANCOUVER, BC – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the manufacturing and clinical development of rare cannabinoids, will report financial results for the fiscal… Read More
VANCOUVER, BC – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the manufacturing and clinical development of rare cannabinoids, today announces that Eric A. Adams, CEO… Read More
EP-104IAR Phase 1 study results published in Osteoarthritis and Cartilage Open Company continues to expand its patent estate for EP-104IAR with patent grant in Israel VICTORIA, BC – Eupraxia Pharmaceuticals… Read More
